Login to Your Account

$125M Deal Sends Mirus Bio Into the Roche RNAi Camp

By Catherine Hollingsworth

Wednesday, July 23, 2008
Roche Holding AG, fresh off its $44 billion offer for Genentech Inc., moved to accelerate its research into RNAi gene silencing technology with the acquisition of Mirus Bio Corp. for $125 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription